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Summary
Background Ultrasound-guided techniques represent 
a new treatment option in the treatment of haemor-
rhoids. Doppler-guided haemorrhoidal artery ligation 
(DG-HAL) proved efficacious in early haemorrhoidal 
disease, but lacks efficacy for stages III/IV. For these 
patients, haemorrhoidal artery ligation (HAL) has been 
combined with a running suture to reduce prolapsing 
haemorrhoidal tissue (recto-anal repair (RAR)).
Methods A prospective observational study was con-
ducted in 184 patients with grade III (58 %) or grade IV 
(42 %) haemorrhoids in seven coloproctological centres. 
Primary endpoints were the recurrence of symptoms 
and need of further treatment (medical or surgical).
Results Post-operative complications were seen in 
8  % of patients. After a follow-up of 3 months, 91  % of 
patients were free of symptoms and 91 % of patients were 
satisfied with the result. After a follow-up of 12 months, 
89  % of patients were free of symptoms and 88  % were 
satisfied with the result. Nineteen per cent of patients 
received further medical or surgical treatment.
Conclusions Doppler-guided recto-anal repair (DG-
RAR) proves to be an effective treatment option for 
the treatment of advanced haemorrhoidal disease that 
shows equal results to other established treatment 
options.
Keywords: Haemorrhoids, Haemorrhoidal artery liga-
tion, Recto-anal repair
Introduction
A variety of treatment options are available for haem-
orrhoidal disease. Whereas early stages of the disease 
can usually be treated conservatively with success, 
advanced stages require a surgical approach. At pres-
ent, surgical treatment generally involves resection of 
the haemorrhoidal cushions, as in conventional haem-
orrhoidectomy (CH) or prolapse reduction as in stapled 
haemorrhoidopexy (SH) [1]. Despite excellent long-term 
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results, CH is associated with significant side effects and 
complications. In addition to excessive post-operative 
pain, symptoms of incontinence and anal stenosis have 
been described in considerable numbers [2–5]. For SH, 
results are more convenient concerning post-operative 
pain. However, reoperations have been reported in up to 
10 % of patients [5, 6] and, albeit very rare, this technique 
can be associated with severe septic complications [5, 7].
Minimally invasive treatment options have become 
popular over the last few decades, even in coloproc-
tology. Doppler-guided haemorrhoidal artery ligation 
(DG-HAL) was first described in 1995 by Morinaga et 
al. [8]. The principle of the technique was to ligate the 
proximal submucosal haemorrhoidal arteries, thereby 
reducing the blood flow to the haemorrhoidal cushions 
and eventually leading to fibrosis and shrinking of the 
haemorrhoids. Haemorrhoidal artery ligation (HAL) has 
since been analysed in several studies, which show excel-
lent results for grade II and III haemorrhoidal disease. 
However, while HAL appears to control pain, bleeding, 
pruritus and mucous discharge with success, control of 
the prolapse seems to be more difficult in patients suf-
fering from grade III or grade IV haemorrhoids. Persis-
tent or recurrent prolapse in grade III disease has been 
described with rates of 6 [9], 9 [10] and 14 % [11]. In stud-
ies involving patients with grade IV disease, even higher 
recurrence rates (RRs) such as 24 [10], 59 [11] and 67 % [9] 
have been observed.
For these patients, in particular those suffering 
from grade IV haemorrhoids, reduction of inflow alone 
seems insufficient to reduce the haemorrhoidal cush-
ions. Recto-anal repair (RAR), a technique developed 
and described by Scheyer [12], addresses this problem 
by supplementing HAL with a further step, whereby the 
haemorrhoidal tissue is gathered up and lifted back into 
position. Based on this principle of tissue reduction, RAR 
is an alternative to surgical removal that is made possible 
by placing a longitudinal running suture while using a 
specially designed proctoscope.
The aim of this prospective observational study for 
grade III and IV haemorrhoidal disease was to review 
several technical aspects and analyze 1-year results of 
this new method (DG-HAL/RAR) in terms of recurrence 
of prolapse and symptoms other than prolapse.
Patients and methods
This study was designed as a prospective observational 
study and was approved by the institutional review 
board. Included in the study were patients between the 
age of 18 and 80 years with symptomatic grade III and IV 
haemorrhoidal disease (according to Goligher classifi-
cation), who had given their informed consent. Patients 
with a history of prior anal surgery and those considered 
unfit for surgery were excluded. Pregnant women and 
those in the puerperium were also excluded. Prior to 
surgery, all patients underwent a detailed examination 
for symptoms of haemorrhoidal disease. A standardised 
form was used to collect data from each patient during 
the study period.
Between March 2007 and December 2007, a total of 
184 patients entered the study in seven proctological 
institutions. The centres contributed a median number 
of 21 patients (range 5–83). Patients were not required to 
enter the study in a consecutive order and the total num-
ber of patients screened was not documented. Of those 
184 patients, 124 were male (65 %) and 64 female (35 %). 
The median age was 46.8 years (range 23–76). The num-
ber of patients suffering from grade III haemorrhoids 
was 107 (58 %), while 77 patients (42 %) were classified 
to suffer from grade IV haemorrhoids. Pain was reported 
by 136 patients (74 %), itching by 139 (76 %) and bleeding 
by 174 (95 %).
The surgical procedure was performed using the DG-
RAR proctoscope (A.M.I. Agency for Medical Innovations 
GmbH) according to the manufacturer’s guidelines. The 
proctoscope consists of an outer and inner tube. In the 
closed position, there is a lateral opening proximal to the 
ultrasound probe that allows detection and ligation of the 
feeding vessels (haemorrhoidal artery ligation). Rotating 
the outer tube of the proctoscope gradually opens a lat-
eral slit to enable placement of a running suture, which 
serves to reduce the anal cushions and secure them back 
in their anatomical position (prolapse reduction). There 
were no recommendations for pain management. Post-
operative pain was assessed using a visual analogue scale 
(VAS). Follow-up with a physical examination and ques-
tioning for recurrence of symptoms and satisfaction was 
performed 3 and 12 months after surgery by the treating 
physician.
Statistical analysis was performed using SPSS V 18.0.0. 
Median and mean were used for descriptive purposes. A 
linear regression analysis was performed to test influence 
of certain variables on recurrence of prolapse, recurrence 
of symptoms and patient satisfaction. A p-value of < 0.05 
was considered significant.
Results
Surgical procedure
A median of six (2–11) ligations and three (range 1–9) 
prolapse-reduction sutures (PRSs) were performed, 
whereby 80 % of patients had six or more ligations, and 
80 % of patients had three or more PRSs. Surgery was per-
formed under general anaesthesia in 132 patients (72 %), 
spinal anaesthesia in 45 (25  %) and local anaesthesia 
in 7 (4 %). The mean operating time was 35 min (range 
13–75). Instances of significant bleeding during the pro-
cedure were observed in three patients (2 %). Post-opera-
tive complications were seen in 14 patients (8 %). Among 
them, 2 patients (1  %) suffered from bleeding which 
required operative revision, 11 patients (7  %) had peri-
anal thromboses and 1 patient (1 %) was diagnosed with 
unspecified proctitis. The mean duration of the hospital 
stay was 2.3 days (range 1–9).
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Post-operative pain
In the immediate post-operative period, i.e. prior to dis-
charge from hospital, 20 % of the patients reported pain 
higher than VAS 4. This gradually diminished by day 4, 
where only 3 % of patients reported pain higher than VAS 
4. Thirteen patients (7 %) reported pain higher than VAS 
7 immediately after surgery. This gradually decreased to 
1 % at day 4. There was only one patient with persistent 
pain for more than 4 days, post-operatively (Table 1).
Recurrence of symptoms
Three months follow-up was completed for all 184 
patients (Table  2). Pain was still present in 14 patients 
(8  %), itching in 19 (10  %) and bleeding in 11 (6  %). 
Twelve patients (7 %) experienced persistent or recurrent 
prolapse. One hundred and sixty-seven patients (91  %) 
were free of symptoms and 168 patients (91 %) were over-
all satisfied with the result of the procedure. Of these 
patients, 28 (15 %) received further treatment including 
CH (1 patient, 1  %), excision of skin tags (12 patients, 
7 %), sclerotherapy (5 patients, 3 %) and treatment with 
an ointment, undefined and by surgeon preference (10 
patients, 5 %).
At 12 month, follow-up was completed for 167 patients 
(92 %). Pain was still present in 10 of these patients (5 %), 
itching in 9 (4  %) and bleeding in 13 (7  %). Persistent 
or recurrent prolapse was experienced by 21 patients 
(11 %). One hundred and fifty-two patients (89 %) were 
free of symptoms and 148 patients (88 %) were satisfied 
with the result of the procedure. Thirty-two patients 
received one or more further treatments (19  %). These 
included CH (n = 2), excision of skin tags (n = 12), sclero-
therapy (n = 5), rubber band ligation (n = 4) and treat-
ment with an ointment, undefined and by surgeon 
preference (n = 13).
Factors influencing outcome
Grade of disease, sex, age and the number of ligations 
and PRSs were tested for their respective influence on the 
recurrence of prolapse or symptoms, and patient satis-
faction. With respect to recurrence of prolapse, there was 
a significant difference between patients with grade III 
and IV disease (Tables 3 and 4). The number of PRSs, and 
in particular the number of ligations, were shown to have 
significant influence on the recurrence of symptoms. 
With respect to symptom recurrence, optimal results 
were obtained with five to seven ligations (median 6) and 
three to four PRSs (median 4). The only factor correlating 
Table 1. Burden of post-operative pain as measured by vi-
sual analogue scale (VAS ~ 1–10)
Time 
(day)
VAS ≤ 3 n (%) VAS 4–6 n (%) VAS ≥ 7 n (%) Total n
1 115 (74.2) 34 (21.9) 6 (3.9) 155
2 102 (79.8) 22 (17.2) 4 (3.1) 128
3 95 (84.8) 12 (10.7) 5 (4.5) 112
4 93 (85.3) 15 (13.7) 1 (0.9) 109
Table 2. Preoperative status compared with 3 and 12 
months post-operative status
Before surgery 
(n = 184; %)
3 months 
(n = 184; %)
12 months 
(n = 167; %)
Pain 136 (73.9) 14 (7.6) 10 (4.8)
Itching 139 (75.5) 19 (10.3) 9 (4.2)
Bleeding 174 (94.6) 11 (5.9) 13 (6.6)
Patient satisfaction 168 (91.3) 148 (87.6)
Prolapse 184 (100) 12 (6.5) 21 (11.4)
Symptom and 
prolapse free
162 (88) 141 (84.4)
Symptom free 167 (90.8) 152 (89.4)
Further treatment 28 (15.2) 32 (18.9)
Table 3. Effectiveness of DG-RAR at 3 and 12 months, 
stratified for grade of haemorrhoidal disease
3 months 12 months
Grade III 
(n = 107; %)
Grade IV 
(n = 77; %)
Grade III 
(n = 99; %)
Grade IV 
(n = 70; %)
Recurrence 
of prolapse
6 (6) 6 (8) 8 (8) 13 (18)
Pain 5 (5) 9 (12) 3 (3) 7 (10)
Itching 9 (8) 10 (13) 2 (2) 7 (10)
Bleeding 3 (3) 8 (10) 2 (2) 8 (11)
Patient 
satisfaction
88.8 94.7 87.0 88.4
Table 4. Multi-variate analysis of factors influencing the parameters of efficacy
Recurrence of prolapse Recurrence of symptoms Patient satisfaction
RR (range) p RR (range) p RR (range) p
Ligations − 0.04 (− 0.83 to 0.16) 0.18 − 0.12 (− 0.17 to − 0.07) 0.0001 0.115 (0.06 to 0.17) 0.0001
Grade 0.14 (0.03 to 0.2) 0.01 0.63 (− 0.38 to 0.16) 0.221 − 0.22 (− 0.13 to 0.09) 0.69
Sex − 0.07 (− 0.17 to 0.03) 0.17 − 0.93 (− 0.19 to 0.01) 0.053 − 0.19 (− 0.7 to 0.32) 0.46
Age 0.004 (0.0 to 0.01) 0.057 0.002 (− 0.003 to 0.00) 0.474 0.02 (− 0.87 to 0.12) 0.77
PRS 0.3 (− 0.17 to 0.08) 0.2 0.052 (0.006 to 0.09) 0.028 0.0 (− 0.01 to 0.04) 0.91
RR recurrence rate, PRS prolapse-reduction suture
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significantly with patient satisfaction was the number of 
ligations.
Complications
One patient (1  %) had anal stenosis-requiring dila-
tion. One patient (1 %) suffered from urinary retention. 
Although considerable time had elapsed between the 
procedure and the onset of urinary retention, no other 
cause could be found. One patient (1  %) reported mild 
faecal incontinence 7 months after the procedure.
Discussion
While a variety of treatment options is available for grade 
I and II haemorrhoids, only SH and CH are considered 
to be a standard treatment for grade III disease, and just 
CH in the case of grade IV. In a meta-analysis [13], the RR 
for prolapse following CH is reported to be 4 %. However, 
both treatment options can be associated with extensive 
post-operative pain [5], faecal incontinence and anal 
stenosis [3]. Nonetheless, for most authors CH remains 
the standard treatment for advanced piles, because 
novel techniques including SH do not show the same 
effectiveness.
Although initial results from single centres have been 
promising [10, 12, 14–17], DG-HAL/RAR has not yet been 
adequately evaluated for grade III and IV haemorrhoids. 
The present study is the first international, multi-centre 
observational trial on the safety and effectiveness of DG-
HAL/RAR. We observed no major intra- or post-operative 
complications. The overall complication rate was 8 %. In 
terms of prolapse recurrence, results achieved by CH at 
12 months are slightly better than those recorded during 
our trial [2]. In terms of control of other symptom, results 
from our series of high-grade HAL/RAR patients were 
superior to those published for CH und SH [2].
Most studies for grade III and IV haemorrhoids focus 
on the recurrence of prolapse, although prolapse may 
not be the leading symptom in a significant number of 
patients. We believe that control of symptoms other than 
prolapse and patient satisfaction is more relevant in eval-
uating efficacy. In terms of pain, pruritus or bleeding, 
almost nine out of ten patients were treated successfully 
and satisfied after a follow-up of 12 months.
In most cases, the variation was due to the persistence 
or development (as a result of shrinkage of haemor-
rhoidal tissue) of skin tags, which subsequently required 
further treatment. This problem is also prevalent among 
patients having undergone CH and SH. In our series, 
7  % of patients required rubber band ligation, sclero-
therapy or haemorrhoidectomy within 12 months of 
undergoing DG-HAL/RAR and 8  % of patients received 
unspecified topical ointments, which we consider to be 
a low number. Taking all the above factors into account, 
we consider that our study demonstrates DG-HAL/RAR 
to be a safe and effective technique for grade III and IV 
haemorrhoids.
Furthermore, our study showed a low degree of post-
operative pain. However, it should be noted that this 
study was not designed to assess post-operative pain for 
DG-HAL/RAR and, as such, pain assessment was only 
performed during the patient’s hospital stay. The greatest 
extent of pain was experienced immediately post-oper-
atively, and the most frequent cause of pain was peri-
anal thrombosis. As the median hospital stay was only 
2 days and patients without post-operative pain would 
have been discharged early, the number of patients with 
higher pain levels may be over-represented. Despite this 
technicality, post-operative pain would appear to be 
quite low. It should be mentioned that some centres per-
formed the DG-HAL/RAR as a day-case procedure, but 
others require an overnight stay due to reimbursement 
considerations. This may have more impact on the length 
of stay than pain alone.
For the first time in a study concerning DG-HAL/RAR, 
a multi-variate analysis was carried out to demonstrate 
the statistically significant influence of various factors 
on parameters of efficacy. The number of PRSs and in 
particular the number of ligations were shown to influ-
ence the recurrence of symptoms, whereas the only fac-
tor affecting the recurrence of prolapse was the grade of 
disease. It is interesting to note that the only factor signif-
icantly influencing patient satisfaction was the number 
of ligations. Our data show a trend towards five to seven 
ligations and three to four PRSs; however, as the number 
of PRSs and ligations depended on each patient’s vascu-
larity as well as the surgeon’s opinion intra-operatively, 
and therefore varied considerably, it is difficult to estab-
lish the optimum number of ligations.
Conclusion
HAL-RAR proved to be safe and effective in the present 
study, showing an acceptable prolapse RR of 11 % after 
12 months for this series of high-grade haemorrhoid 
patients (59 % grade III, 41 % grade IV). Symptom control 
and patient satisfaction are high, resulting in approxi-
mately nine out of ten patients staying symptom-free and 
satisfied 1 year after surgery. The perioperative compli-
cations, which were low in number, were primarily cases 
of perianal thrombosis and post-operative bleeding. 
However, to answer the question of the optimum treat-
ment modality (CH, SH and DG-HAL/RAR) for advanced 
haemorrhoidal disease, a controlled randomized trial 
would be needed. A multi-centre approach seems man-
datory, because no single institution will be able to enrol 
enough patients or perform all three techniques with 
adequate experience. However, fully informed consent 
for such a trial may be problematic. In the absence of 
such a trial, the nine centres contributing to this study 
have chosen HAL-RAR as their first-line treatment for 
high-grade haemorrhoids owing to the perioperative 
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benefits, very low number of complications, good symp-
tom control and acceptably low RR.
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